Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The rise of interventional pulmonology: A special issue coordinated by the GETIF].
Guibert N, Dutau H, Escarguel B, Egenod T, Fournier C, Legodec J, Trosini-Desert V, Lorut C, Lachkar S, Vergnon JM. Guibert N, et al. Among authors: egenod t. Rev Mal Respir. 2022 May;39(5):409-410. doi: 10.1016/j.rmr.2022.04.001. Epub 2022 May 12. Rev Mal Respir. 2022. PMID: 35570032 French. No abstract available.
Pneumatocoeles after bronchoscopic lung volume reduction with valves.
Lestelle F, Fumat R, Didier A, Collot S, Egenod T, Faviez G, Hermant C, Plat G, Guibert N. Lestelle F, et al. Among authors: egenod t. ERJ Open Res. 2021 Apr 6;7(2):00747-2020. doi: 10.1183/23120541.00747-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 33834053 Free PMC article.
Two-Stage Bronchoscopic Endobronchial Valve Treatment Can Lead to Progressive Lung Volume Reduction and May Decrease Pneumothorax Risk.
Egenod T, Tricard J, Fumat R, Simonneau Y, Favard F, Guillot MS, Collot S, Dupuis M, Melloni B, Vergnenegre A, Guibert N, Dusselier M. Egenod T, et al. Int J Chron Obstruct Pulmon Dis. 2021 Jun 28;16:1957-1965. doi: 10.2147/COPD.S307829. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34234426 Free PMC article.
Bilateral endobronchial valves treatment for severe emphysema.
Guibert N, Fumat R, Dupuis M, Dusselier M, Favard F, Heluain V, Mallah S, Barthes R, Simonneau Y, Egenod T. Guibert N, et al. Among authors: egenod t. ERJ Open Res. 2022 Apr 11;8(2):00672-2021. doi: 10.1183/23120541.00672-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35415190 Free PMC article.
[Bronchoscopic COPD treatments].
Egenod T, Deslee G, Degano B. Egenod T, et al. Rev Mal Respir. 2023 Nov-Dec;40(9-10):820-833. doi: 10.1016/j.rmr.2023.08.003. Epub 2023 Sep 6. Rev Mal Respir. 2023. PMID: 37684196 Review. French.
Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers.
Dusselier M, Deluche E, Delacourt N, Ballouhey J, Egenod T, Melloni B, Vergnenègre C, Veillon R, Vergnenègre A. Dusselier M, et al. Among authors: egenod t. PLoS One. 2019 Jul 17;14(7):e0219060. doi: 10.1371/journal.pone.0219060. eCollection 2019. PLoS One. 2019. PMID: 31314761 Free PMC article.
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study.
Barlesi F, Dixmier A, Debieuvre D, Raspaud C, Auliac JB, Benoit N, Bombaron P, Moro-Sibilot D, Audigier-Valette C, Asselain B, Egenod T, Rabeau A, Fayette J, Sanchez ML, Labourey JL, Westeel V, Lamoureux P, Cotte FE, Allan V, Daumont M, Dumanoir J, Reynaud D, Calvet CY, Ozan N, Pérol M. Barlesi F, et al. Among authors: egenod t. Oncoimmunology. 2020 Apr 12;9(1):1744898. doi: 10.1080/2162402X.2020.1744898. Oncoimmunology. 2020. PMID: 33457089 Free PMC article. Clinical Trial.
20 results